AI will revolutionize drug discovery — but only if experts are involved

To fruitfully apply AI to drug discovery, we need better feedback loops between developers and interdisciplinary teams that test the technology.

Smaller, lighter, cheaper: A serial entrepreneur wants his portable MRI to transform medicine

In a nondescript building in a Connecticut town sits a prototype that could change the way that doctors use MRIs.

New leaders needed to translate discoveries into patient care

To facilitate new discoveries, today's and tomorrow's leaders need to understand and navigate the languages and cultures of multiple sectors, from health care systems and academia to industry, finance, and government.

Biotech incubator LabCentral to double its space in Boston

LabCentral, the biotech incubator in Cambridge, Mass., that has nurtured dozens of startups in a shared working space, plans to roughly double in size in two years.

A new global initiative aims to use AI to improve public health in the developing world

A new effort, led by the Rockefeller Foundation, is aimed at delivering cutting-edge tech to parts of the world that have been slow to benefit from it — and improving public health in the process.

Artificial intelligence for medicine needs a Turing test. Obesity would be a good one

Demonstrating that artificial intelligence can create an effective alternative to weight-loss surgery would show the skeptics what medical AI can do. If it can't do this, it's time for medical AI to go home.

Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

How patient records from one Boston hospital fueled an explosion in AI research in medicine

Patients’ de-identified medical records from one Boston hospital have become a crucial cog in a burgeoning field of artificial intelligence research.

‘Jumping genes’ could help CRISPR replace disease-causing DNA, study finds

A "jumping gene" might be harnessed to help CRISPR insert a string of healthy DNA in place of a disease-causing sequence.

Study highlights challenges in using artificial intelligence to personalize cancer treatment

A new study details the challenges of using natural language processing, a subtype of AI, to identify patients likely to respond to targeted cancer therapies.

Aim your baloney detector at the BS in health care

Health care has an acute BS problem. Just think of Theranos and IBM Watson. Thanks to social media, it can spread faster and farther than the truth.

Pharmalittle: Sanofi pledge to rebuild Notre Dame gets backlash; IBM halts AI product for drug development

Sanofi pledged about $11 million for rebuilding Notre Dame, but reaction has been mixed.

IBM halting sales of Watson AI tool for drug discovery amid sluggish growth

IBM is halting development and sales of its Watson artificial intelligence software to help pharmaceutical companies discover new treatments.

Paging Dr. Topol: Grasping the multidimensional narrative of ‘Deep Medicine’

The medical mind has limitations — a physician can know the signs of only a fraction of the 10,000 or so human diseases. Powerful tools like AI and machine learning can help transcend those limits.

Bristol-Myers Squibb turns to an AI startup to accelerate cancer research

Bristol-Myers Squibb, seeking to re-energize its cancer pipeline, is turning to an artificial intelligence startup, Concerto, to accelerate its clinical trials by using real-world data. $BMY

Peering inside life’s microworld: MIT’s 2019 image award winners

To honor advances in the visualization of biological processes, MIT's @kochinstitute sets up an annual exhibit in its lobby. Check out this year's selections:

A believer in biotech and big data: How Ned Sharpless vaulted to the top of the FDA

Almost immediately after taking over as the nation’s top cancer researcher, Ned Sharpless built a roughly 7-mile detour into his weekly routine: a sojourn to the FDA campus for a pickup basketball game.

UnitedHealth will require drug rebates to be paid to consumers

UnitedHealth Group will require employers that hire its OptumRx pharmacy benefit manager to pass rebates to individuals who take the medicines.

Ned Sharpless, director of the National Cancer Institute, to be named acting FDA commissioner

Sharpless, who led a pioneering cancer research team at the University of North Carolina for over a decade, has led NCI since October 2017.

Lab strips James Watson of final honorary roles after his continuing racist statements

In a recent documentary, Watson refused to take back statements widely regarded as racist.

IBM isn’t retreating from using Watson in health care, CEO Rometty says

CEO Ginni Rometty spoke little about health care during an hourlong talk at #CES19, but afterward insisted that “Watson Health is a very important part” of IBM’s business.

At glitzy Vegas tech show, chronic-disease gadgets to take center stage

As the Consumer Electronics Show kicks off, experts caution that the real-world results of digital health products have not caught up to the promises made in press releases. #CES19

‘I really don’t know what happened to Jim’: Friends ask where James Watson’s odious attitudes about race came from

Watson saw his double-helix discovery as proof of his view that intuition and opposing the establishment consensus are stronger guides to truth than empirical research.

Flu picks up & new James Watson documentary

The STAT Morning Rounds newsletter keeps you ahead of the day's health and science news.

2018 in limericks: The highs and lows from the life sciences

What a year it's been in the life sciences: CRISPR babies and IPOs galore, high-priced CAR-Ts and gene therapies. We remember it all with the 2018 edition of our year in review in limericks.

We wish we’d written that: STAT staffers share their favorite stories of 2018

It's time for STAT's annual admission of jealousy: We share our favorite stories of 2018 — that we wish we would have written.

LISTEN: Watson’s latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

What will become of biotech in 2019? What's the legacy of Sarepta Therapeutics? And how do you say "overhyped" in Mandarin?

In last-ditch move, lawmakers push to renew pandemic preparedness bill before end of year

The House passed a long-stalled public health bill Thursday, sending it to the Senate in a last-ditch attempt to get the law passed before the end of the year.

IBM Watson’s bet on China, a lucrative market for health business, starts to look shaky

EXCLUSIVE: Though IBM Watson is being used to treat #cancer patients in #China, the company is scrambling to respond to the same doubts that emerged about the technology in the U.S. and Europe.

Your daily dose of news in health and medicine

Privacy Policy